Literature DB >> 8540721

In vitro antimycobacterial activities of pyrazinamide analogs.

S Yamamoto1, I Toida, N Watanabe, T Ura.   

Abstract

We synthesized various pyrazine derivatives and pyrazinamide analogs and assayed their antimycobacterial activities in vitro in order to find new drugs which are more active against Mycobacterium tuberculosis than pyrazinamide and also active against Mycobacterium avium and Mycobacterium intracellulare. Of the drugs synthesized, four drugs, namely, pyrazine thiocarboxamide, N-hydroxymethyl pyrazine thiocarboxamide, pyrazinoic acid n-octyl ester, and pyrazinoic acid pivaloyloxymethyl ester, were not only bacteriostatic but also bacteriocidal against these three species of mycobacteria in vitro under conditions in which pyrazinamide showed no or little activity. In conclusion, these four drugs are possible candidates for new antimycobacterial agents, and animal experiments are now under way.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8540721      PMCID: PMC162886          DOI: 10.1128/AAC.39.9.2088

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

Review 1.  Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.

Authors:  C R Horsburgh
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

2.  Activation of pyrazinamide and nicotinamide in acidic environments in vitro.

Authors:  W McDERMOTT; R TOMPSETT
Journal:  Am Rev Tuberc       Date:  1954-10

3.  Pyrazinamide (aldinamide) in the treatment of pulmonary tuberculosis.

Authors:  R L YEAGER; W G C MUNROE; F I DESSAU
Journal:  Am Rev Tuberc       Date:  1952-05

4.  Pyrazinamide (aldinamide) in experimental tuberculosis of the guinea pig.

Authors:  F I DESSAU; R L YEAGER; F J BURGER; J H WILLIAMS
Journal:  Am Rev Tuberc       Date:  1952-05

5.  A method for the determination of in vitro sensitivity of tubercle bacilli to pyrazinamide (aldinamide).

Authors:  F I DESSAU; F BURGER; R L YEAGER; M KULISH
Journal:  Am Rev Tuberc       Date:  1952-05

6.  The effect of pyrazinamide (aldinamide) on experimental tuberculosis in mice.

Authors:  L MALONE; A SCHURR; H LINDH; D McKENZIE; J S KISER; J H WILLIAMS
Journal:  Am Rev Tuberc       Date:  1952-05

Review 7.  The role of pyrazinamide in tuberculosis chemotherapy.

Authors:  M A Steele; R M Des Prez
Journal:  Chest       Date:  1988-10       Impact factor: 9.410

8.  Does pyrazinoic acid as an active moiety of pyrazinamide have specific activity against Mycobacterium tuberculosis?

Authors:  L B Heifets; M A Flory; P J Lindholm-Levy
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

9.  Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method.

Authors:  M Salfinger; L B Heifets
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

10.  The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug.

Authors:  R M MCCUNE; W MCDERMOTT; R TOMPSETT
Journal:  J Exp Med       Date:  1956-11-01       Impact factor: 14.307

View more
  4 in total

1.  Inhaled Pyrazinoic Acid Esters for the Treatment of Tuberculosis.

Authors:  E F Young; E Perkowski; S Malik; J D Hayden; P G Durham; L Zhong; J T Welch; Miriam S Braunstein; Anthony J Hickey
Journal:  Pharm Res       Date:  2016-06-28       Impact factor: 4.200

2.  When biomolecules meet 2-hydrazinopyrazine: from theory through experiment to molecular levels using a wide spectrum of techniques.

Authors:  Paulina Mech; Mariusz Makowski; Anna Kawiak; Agnieszka Chylewska
Journal:  RSC Adv       Date:  2020-11-09       Impact factor: 4.036

3.  Purification, gene cloning, targeted knockout, overexpression, and biochemical characterization of the major pyrazinamidase from Mycobacterium smegmatis.

Authors:  H I Boshoff; V Mizrahi
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

4.  N-Pyrazinoyl Substituted Amino Acids as Potential Antimycobacterial Agents-The Synthesis and Biological Evaluation of Enantiomers.

Authors:  Martin Juhás; Lucie Kučerová; Ondřej Horáček; Ondřej Janďourek; Vladimír Kubíček; Klára Konečná; Radim Kučera; Pavel Bárta; Jiří Janoušek; Pavla Paterová; Jiří Kuneš; Martin Doležal; Jan Zitko
Journal:  Molecules       Date:  2020-03-27       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.